A study of belimumab in Chinese Pediatric Participants with Systemic Lupus Erythematosus

Trial Identifier: 217091
Sponsor: GlaxoSmithKline
Start Date: July 2023
Primary Completion Date: October 2024
Study Completion Date: October 2024
Condition: Lupus

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
China Beijing, China, 100045
China Changsha, China, 410007
China Hangzhou, China, 310052
China Nanjing, China, 210011
China Shanghai, China, 361006
China Suzhou, China, 215007